Physician profile
Boris Bagdasarian
NPI 1598758062
$37,768.53
in general payments reported to CMS, 2019-2025
97 companies · $7,192 in 2025
The $7,192 reported for 2025 was more than what 85% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,154 · 2020: $4,903 · 2021: $3,825 · 2022: $4,723 · 2023: $5,466 · 2024: $6,506 · 2025: $7,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Long Term Medical Supply Or Device Loan: $1,446 · Education: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,595.00 |
| Long Term Medical Supply Or Device Loan | $1,446.39 |
| Education | $1,122.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,210.28 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,336.04 | 2019-2025 | Enhertu, Tagrisso, Imfinzi |
| Pfizer INC. | $1,812.53 | 2019-2025 | |
| Janssen Biotech, INC. | $1,724.41 | 2019-2025 | Erleada, Rybrevant, Darzalex |
| Incyte Corporation | $1,609.08 | 2019-2025 | Jakafi, Monjuvi, Niktimvo |
| E.R. Squibb & Sons, L.L.C. | $1,598.50 | 2019-2025 | Opdivo, Opdualag, Orencia |
| Merck Sharp & Dohme LLC | $1,578.93 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $1,467.52 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Puma Biotechnology, INC. | $1,454.93 | 2019-2024 | Nerlynx |
| Genzyme Corporation | $1,323.59 | 2019-2025 | |
| Amgen INC. | $1,262.71 | 2019-2025 | Lumakras, Imdelltra (Amg757) |
| Genentech USA, INC. | $1,248.65 | 2019-2025 | Venclexta, Phesgo, Polivy |
| Astellas Pharma US INC | $1,128.41 | 2019-2025 | Xospata, Xtandi, Vyloy |
| Bayer Healthcare Pharmaceuticals INC. | $982.11 | 2019-2025 | |
| Seagen INC. | $929.31 | 2020-2025 | Adcetris, Padcev, Tivdak |
Show all 97 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $849.54 | 2019-2025 | Iclusig, Fruzaqla, Ninlaro |
| Eisai INC. | $766.56 | 2020-2025 | |
| Lilly USA, LLC | $714.27 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Exelixis INC. | $709.94 | 2020-2025 | Cabometyx |
| Karyopharm Therapeutics INC. | $695.30 | 2020-2025 | Xpovio |
| Blueprint Medicines Corporation | $572.66 | 2020-2025 | Ayvakit |
| Gilead Sciences, INC. | $516.29 | 2019-2025 | Trodelvy |
| Alexion Pharmaceuticals, INC. | $493.02 | 2019-2025 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $486.33 | 2019-2025 | Gilotrif |
| Tersera Therapeutics LLC | $484.82 | 2020-2025 | Zoladex, Xermelo, Quzyttir |
| Abbvie INC. | $474.97 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $399.54 | 2020-2025 | Libtayo, Lynozyfic |
| Array Biopharma INC | $381.42 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Daiichi Sankyo INC. | $337.84 | 2019-2025 | Enhertu |
| Emd Serono, INC. | $308.96 | 2019-2025 | Bavencio |
| Kite Pharma, INC. | $306.58 | 2020-2025 | Yescarta |
| Glaxosmithkline, LLC. | $281.00 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Pharmaessentia USA Corporation | $262.50 | 2022-2025 | Besremi |
| Pharmacyclics LLC, An Abbvie Company | $232.30 | 2019-2022 | |
| Caris Mpi, INC. | $224.76 | 2025 | Mi Cancer Seek |
| Teva Pharmaceuticals USA, INC. | $203.03 | 2019-2020 | |
| Taiho Oncology, INC. | $193.26 | 2020-2025 | |
| Sobi, INC | $186.45 | 2022-2025 | |
| Dova Pharmaceuticals | $180.32 | 2019-2021 | |
| Beigene USA, INC. | $167.58 | 2020-2024 | Brukinsa |
| Genmab U.S., INC. | $165.66 | 2024-2025 | Epkinly |
| Adc Therapeutics America, INC. | $146.96 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $144.81 | 2023 | Erleada |
| Tolmar Pharmaceuticals, INC. | $144.72 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $138.07 | 2022-2024 | |
| Rigel Pharmaceuticals, INC. | $136.80 | 2019-2023 | Rezlidhia, Tavalisse |
| Stemline Therapeutics INC. | $135.64 | 2023-2025 | Orserdu |
| Clovis Oncology, INC. | $131.21 | 2019-2022 | |
| Mirati Therapeutics, INC. | $129.26 | 2023-2024 | Krazati |
| Tesaro, INC. | $119.24 | 2019 | |
| Deciphera Pharmaceuticals INC. | $115.98 | 2023-2025 | Qinlock, Romvimza |
| Coherus Oncology, INC. | $114.55 | 2020-2025 | Loqtorzi |
| Geron Corporation | $114.43 | 2025 | Rytelo |
| Kyowa Kirin, INC. | $113.35 | 2019-2022 | |
| Immunocore Limited | $107.45 | 2024 | Kimmtrak |
| Beone Medicines USA, INC. | $84.84 | 2025 | Tevimbra, Brukinsa |
| Agios Pharmaceuticals, INC. | $80.55 | 2020-2025 | Pyrukynd |
| Aurobindo Pharma USA, INC. | $75.52 | 2019 | |
| Jazz Pharmaceuticals INC. | $73.94 | 2024-2025 | |
| Legend Biotech USA INC. | $72.21 | 2025 | Carvykti |
| Lexicon Pharmaceuticals, INC. | $69.69 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $69.28 | 2021-2025 | Somatuline Depot, Onivyde |
| Immunogen, INC. | $66.74 | 2023 | Elahere |
| Amag Pharmaceuticals, INC. | $62.80 | 2020-2021 | |
| Secura Bio, INC. | $61.02 | 2019-2021 | |
| Morphosys, US INC. | $60.70 | 2022-2023 | Monjuvi |
| Organon LLC | $59.69 | 2021-2023 | Ontruzant |
| Verastem, INC. | $56.91 | 2019 | |
| Tempus Ai, INC | $54.71 | 2024-2025 | Xt Cdx |
| Syndax Pharmaceuticals, INC. | $48.85 | 2025 | |
| Acrotech Biopharma INC. | $46.82 | 2021-2025 | Beleodaq |
| Novocure INC. | $43.00 | 2019-2021 | |
| Foundation Medicine, INC. | $41.83 | 2020-2023 | |
| Ge Healthcare | $38.59 | 2022 | |
| Spectrum Pharmaceuticals INC. | $34.87 | 2019-2023 | Rolvedon |
| Chiesi USA, INC. | $34.68 | 2022-2024 | Ferriprox |
| Apellis Pharmaceuticals, INC. | $31.76 | 2024 | Empaveli |
| Octapharma USA, INC. | $30.42 | 2023 | Panzyga |
| Springworks Therapeutics, INC. | $29.86 | 2024 | Ogsiveo |
| Pharmacosmos Therapeutics INC. | $28.92 | 2024 | Monoferric |
| Progenics Pharmaceuticals, INC. | $26.78 | 2025 | |
| Emmaus Medical, INC. | $25.43 | 2021 | |
| Integra Lifesciences Corporation | $25.24 | 2020 | |
| Servier Pharmaceuticals LLC | $24.63 | 2025 | |
| Myriad Genetic Laboratories, INC. | $24.52 | 2021 | |
| Acceleron Pharma, INC. | $23.52 | 2020 | |
| Sanofi-Aventis U.S. LLC | $22.99 | 2019 | |
| Heron Therapeutics, INC. | $22.02 | 2019 | |
| Epizyme, INC. | $20.70 | 2020 | |
| Aveo Pharmaceuticals, INC. | $20.27 | 2023 | Fotivda |
| Verity Pharmaceuticals INC. | $20.04 | 2023 | Trelstar |
| Sirtex Medical INC | $19.32 | 2020 | |
| Fennec Pharmaceuticals, INC. | $18.65 | 2024 | Pedmark |
| Azurity Pharmaceuticals, INC. | $18.45 | 2025 | Danziten |
| Janssen Pharmaceuticals, INC | $17.82 | 2019 | |
| Eusa Pharma (US) LLC | $13.91 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Bagdasarian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.